Fall 2023 Partnership Pulse
As we look forward to the holiday season, we are filled with gratitude to all our incredible partners. […]
Category: Blog
Uncovered Barriers to Clinical Trial Enrollment Among Patients with Non-Hodgkin’s Lymphoma
Clinical trials are crucial for advancing care for non-Hodgkin’s lymphoma (NHL), however, accrual in these studies remains low. To address this issue, PlatformQ Health, the Leukemia & Lymphoma Society, BlackDoctor.org, and Partners for Advancing Clinical Education co-produced the BUILD-NHL Trial Equity Initiative. […]
Driving Equitable Healthcare through Patient and Provider Education
PlatformQ Health, the Asthma and Allergy Foundation of America (AAFA), and BlackDoctor.org were seeking to understand whether aligned (sequential patient/provider) education could help improve health equity for those suffering from conditions such as asthma and atopic dermatitis. […]
Unexamined Ways to Drive Clinical Trial Enrollment
Clinical trial recruitment has been a persistent problem, with studies showing up to 55% of trials are canceled prematurely due to low enrollment rates. These rates are even more dismal when it comes to diverse populations, including ethnic and racial minorities as well as seniors. Common methods for improving trial access such as transportation supports have been well documented, yet there are numerous other avenues for improving the patient experience that have yet to be uncovered. […]
Program Outcomes Demonstrate High Need for Immunotherapy Education
Immunotherapy is increasingly being used to treat patients with melanoma and other types of cancer. Management of these therapies differs distinctly from previous standard-of-care options such as chemotherapy. Optimizing care involves educating a multidisciplinary healthcare team about therapy management as well as educating patients about therapies and the factors that can influence outcomes. […]
High Need for Patient and Provider Education Amid Approval of Anti-FcRn Agents and C5 Inhibitors
In the wake of FDA approvals for treating myasthenia gravis (gMG, healthcare providers have the ability to individualize treatment. As these new therapies become adopted, it’s crucial to educate patients and providers about issues such as disease presentation, comorbidities, and patient preferences that may impact treatment decisions. […]
A Pressing Need for Gene and Cell Therapy Education
The explosion of gene and cell therapies brings promise – and a plethora of questions – from patients and healthcare providers. CAR T-cell therapy is a notable example. These one-time treatments are providing durable remission and in some cases cures of recurrent blood cancers. Due to the complexity of CAR T-cell therapy, it is currently available exclusively at specialized medical centers. […]
Multi Stakeholder Collaborations Poster Selected for NORD’s Lightning Round Poster Presentation
PlatformQ Health is excited to share that our poster session “Incorporating the Patient Voice in Rare Disease Education: Multi Stakeholder Collaborations to Improve Diagnosis, Quality of Care, and Outcomes” was selected to be presented both at the 2023 NORD Breakthrough Summit and at the Lighting Round Poster Presentations taking place from 4:30-5:00 PM on Monday, October 16. […]
Educational Initiatives in gMG, DMD and SMA
Numerous posters of educational outcomes have been published at major conferences over the past three years across neuromuscular conditions, including Duchenne muscular dystrophy (DMD), myasthenia gravis (mGM), and spinal muscular atrophy (SMA). These posters highlight the advantages of aligned patient/provider education for closing knowledge gaps and aligning expectations between patients and providers. […]
Summer 2023 Partnership Newsletter
It’s been a busy season here at the Q, with many educational programs launching across therapeutic areas. Thanks to partnerships with leading advocacy and membership organizations, we have been able to extend access to our trusted education to even more patients, families, and health care providers. Program Highlight We’re particularly excited to share that we’ve […]
Making Behavioral Changes in Clinical Trial Representation
There has been much discussion in the medical community about the imperative to improve equity in clinical trials, but what really helps when it comes to changing patient and provider perceptions? […]
Lighting the Way Forward: Addressing Depression in People Facing Diminished Vision
Being diagnosed with macular degeneration is a shock to most patients, some of whom have no symptoms at the time. The prospect of losing some, or all of your sight can be devastating, and often leads to depression, as patients worry over the potential loss of independence and changes to their lives. […]
Join Us for a Conversation about Improving Equity in Clinical Trials
We’re proud to sponsor the 3rd annual Chief Patient Officer Summit, and to participate in an important conversation about improving equitable representation in clinical trials. With five years of producing digital education focused on trial diversity, we’re pleased to be able to share insights into strategies that can change behaviors and break down barriers to trial enrollment. […]
Young Woman Forms the Chrysalis Initiative Amid Stage 4 Cancer Diagnosis
“Black women are 71% more likely to die of breast cancer than their White counterparts, so you have to question what is going on here,” she says. “Although there was knowledge in the medical community about inequities, it seemed like the default response was that this was all associated with poverty or lack of insurance, but what I found is that it’s more nuanced than that. There was bias that was contributing to these disparities. Even if a Black woman had adequate insurance and income, she was often not being presented with the standard of care.” […]
Advancing Alzheimer’s Disease Management – Strategies for Early Diagnosis
Dementia is one of the biggest global health crises of the 21st century, according to leading neurologists. More than 50 million people are living with the disease, and that number is expected to triple by 2050. Roughly 60-80 percent of dementia cases are Alzheimer’s disease. Specialists are raising awareness that neurodegeneration can begin years, and sometimes decades before a person becomes symptomatic. This is one reason early diagnosis is so crucial. […]
LUGPA Extends Partnership with PlatformQ Health
BOSTON AND CHICAGO, APRIL 19, 2023 – and PlatformQ Health have extended their partnership to deliver cutting-edge digital education to the urology community. […]
Seth Gordon Joins PlatformQ Health as General Manager of Digital Solutions
PlatformQ Health is pleased to announce that noted industry leader Seth Gordon has joined the organization in a senior business development and management role, supporting pharmaceutical clients seeking digital solutions to engage and educate healthcare providers and patients online. […]
Reducing Disparities in Alzheimer’s Care: Creating Opportunities to Optimize Brain Health
Global cases of Alzheimer’s disease (AD) are expected to triple by 2050, according to a recent study presented at the Alzheimer’s Association International Conference. African American and Hispanic American communities are disproportionately affected by the disease, with African Americans having two to three times more instances and Hispanic Americans having 1.5 times more instances of […]
Novel Approaches to Closing Educational Gaps – A Serialized Tethered Education Initiative in CLL
A pre-recorded, moderated panel discussion featuring stakeholders in CME, patient education, industry, and medical education. […]
The Power of Continuing Medication Education to Enhance Health Care Providers’ Index of Suspicion of Rare Dermatologic Conditions
Education about rare diseases is crucial to reducing time to diagnosis and providing optimal care for patients. Recently, PlatformQ Health worked with our strategic partner the National Organization for Rare Disorders (NORD) to produce digital education for health care providers (HCPs), focused on the rare dermatological condition prurigo nodularis. The 60-minute continuing medication education (CME) […]
PlatformQ Health Secures Two Posters at 2023 American Academy of Neurology Annual Meeting
The digital education firm PlatformQ Health had two posters accepted at the 2023 American Academy of Neurology Annual Meeting, held in Boston from April 22-27, 2023. The company regularly shares outcomes from its health care provider (HCP) and patient-focused educational programs. During the annual meeting, PlatformQ Health’s posters focused on the results of recent HCP educational programs focused on Rett syndrome and Alzheimer’s disease. […]
A Patient-Centric Outcomes Approach That Impacted 26 Million Patients in 2022
PlatformQ Health had 20 posters accepted at major medical and healthcare conferences during 2022. We’re pleased to share the posters, highlighting key outcomes from our educational initiatives across an array of therapeutic areas. Oncology 2022 Alliance Industry Summit Supplemental Digital Resources CME Program Closes Critical Knowledge Gap in Cancer Immunotherapy Treatment Presenting Education Outcomes at […]
Online Education Sheds Light on Gaps in Care for Chronic Spontaneous Urticaria
Patients with chronic spontaneous urticaria (CSU) often suffer with unresolved symptoms, despite numerous visits to different healthcare providers. In a recent poster presented at the 2023 American Academy of Allergy, Asthma, and Immunology, PlatformQ Health evaluated the impact of digital continuing medical education (CME) on optimizing diagnosis as well as antihistamine dosing. […]
Four-part Digital Education Fosters Clinical Practice Changes in Gastric and Gastroesophageal Junction Adenocarcinomas
Gastric or gastroesophageal junction (GEJ) adenocarcinomas are notoriously difficult to treat, but recently approved immune checkpoint inhibitors and HER2-directed antibody drug conjugates are improving outcomes for patients with these conditions. While these advances are a positive change, they do pose challenges for healthcare providers who need to learn about new regimens and practices. […]
Navigating the New World of Microlearning: Reaching and engaging specialists
As many continuing medication education (CME) program funders will tell you, finding ways to reach medical specialists is often a conundrum. Not only is their time in high demand but they have a plethora of choices when it comes to continuing education. […]
Winter 2022 Partnership Newsletter
A Look Back on 2022 – Connecting patients, providers, and caregivers through education As we reflect on the past year, we are particularly grateful for the connections we made with our partners, supporters, and colleagues. These connections helped us develop meaningful patient and provider education that impacted 22 million patients. Moving the needle in healthcare […]
Tethered Education Identifies Gaps in TNBC Care and Perceptions
Vast racial disparities exist in triple-negative breast cancer (TNBC), yet many patients and providers are aware of these issues. Women of the African Diaspora (WAD) are often diagnosed at a more advanced stage and experience higher rates of TNBC-related mortality. Though the TNBC treatment landscape has changed with the influx of new clinical data and newly approved treatments, there is much education needed to ensure patients and the medical community are aware of these advances. […]
Timelapse of Patient and Provider Surveys Reveals Valuable Insights for CLL Educational Needs
Targeted treatment regimens have significantly improved overall survival for patients with chronic lymphocytic leukemia (CLL). The emergence of new options such as BTK inhibitors has shifted the treatment landscape significantly, bringing a pressing need for education for providers, patients, and caregivers. […]
Four-part CME Series Empowers Clinicians Caring for Patients with Rare Diseases
Patients with rare diseases are anxious to find a cure, yet roughly only half ever receive a proper diagnosis. Many of these patients return to their primary care providers (PCPs) frustrated. […]
Two-part Educational Program Improves Physician Competency in Immunotherapies
The growth of immunotherapies has shifted the standard of care for treating many solid tumors. As new indications are approved, there is a growing need for clinician education in this space. […]
Engaging and Educating Rare Disease and Cancer Patients Online through Financial Literacy
More than half of Americans face financial difficulties paying for medical treatment, according to a recent study. This is particularly relevant in rare diseases and cancer and exacerbates health issues while causing mounting anxiety. […]
Patient Voice Helps Healthcare Providers Better Understand Treatment Expectations for Heart Condition
Early diagnosis and treatment of homozygous familial hypercholesterolemia (HoFH) are key to reducing patients’ risk, yet there is low awareness of current guidelines and treatment options among healthcare practitioners. […]
CME Programs Increases Competency in Managing Neuroendocrine Tumors
Targeted therapies have allowed for better management of neuroendocrine tumors (NETs), yet this requires that healthcare providers glean new knowledge about treatment options such as somatostatin analogs. To improve provider competency and include consideration of patient perspectives in treatment selection, PlatformQ Health and Healing NET Foundation teamed up with the Moffitt Cancer Center to produce a free educational initiative for providers. […]
CME Education Proves Beneficial for Helping Clinicians Understand Rapidly Changing Generalized Myasthenia Gravis (gMG) Treatment Options
In the face of a rapidly shifting landscape of targeted therapies for treating gMG, PlatformQ Health, the National Organization for Rare Disorders (NORD), and the University of North Carolina at Chapel Hill collaborated to develop online CME education about the management of this disease. […]
NORD Summit: Rare Disease Education Designed to Improve Diagnosis, Quality of Care and Outcomes
Patients often face an epic journey of many years before receiving a diagnosis for a rare disease. With nearly one in 10 Americans impacted by a rare condition, it is essential that we decrease the time to diagnosis to improve the lives of these individuals and their families. […]
51st CNS Annual Meeting: Presenting Educational Outcomes on Aligning Patient/Caregiver Roles in Developmental and Epileptic Encephalopathies
The management of developmental and epileptic encephalopathies (DEEs) has shifted in recent years, necessitating changes in treatment decisions. In the wake of these changes, PlatformQ Health, the National Organization for Rare Disorders, the Lennox Gastaut Syndrome Foundation, and the University of California, San Francisco came together to produce aligned, online continuing education to support healthcare providers in their ability to diagnose and treat DEEs and help caregivers to engage in care. […]
National Organization for Rare Disorders (NORD) and PlatformQ Health Extend Educational Partnership to Improve Patient Outcomes
Ongoing clinician and public education on rare diseases is critical to raising the index of suspicion, decreasing the time to diagnosis, and providing optimal management of patients with these conditions. […]
Fall Partnership Newsletter – Improving Health Outcomes, Clinical Trial Education & New Tethered Program Initiatives
In our latest partnership newsletter, we highlight some of our recent educational initiatives that address clinical trial equity, tethered education, strategies to improve CME outcomes and more! […]
7 Strategies to Improve CME Outcomes
High-quality education takes shape when the needs of patients and providers are anticipated and met through an ever-evolving education model. […]
ASCO Quality Care Symposium 2022: Patient Voice Helps Improve Point-of-Care for Urothelial Carcinoma
PlatformQ Health presents a poster at the 2022 ASCO Quality Care Symposium on educational outcomes in Urothelial Carcinoma. […]
MGFA Scientific Session at AANEM: Myasthenia Gravis CME Program Improves Patient Outcomes
Educational outcomes from “Evolving Treatment Approaches for Generalized Myasthenia Gravis to Reduce Disease Burden and Improve Daily Living” accepted at the MGFA Scientific Session at the 2022 AANEM Conference. […]
CancerCare, BlackDoctor.org, and TOUCH: The Black Breast Cancer Alliance Collaborate with PlatformQ Health to Promote Diversity in Breast and Lung Cancer Clinical Trials
People of color, the elderly, as well as those living in rural areas are disproportionately affected by cancer, yet are severely underrepresented in cancer clinical trials. The lack of diversity in clinical trials leaves these patients at a severe disadvantage because there is little insight into the safety and effectiveness of therapies for them. […]
Breaking Down Barriers Between Patients & Providers
When confronting a frightening condition like bladder cancer, patients may fall into a rabbit hole of information online. It can be challenging to discern what sites to trust and where to turn. Not only are patients facing concerns about their own survival, but also worries over sensitive issues such as bladder function and sexual health. In this situation, it can be difficult for patients to open up to providers about their fears. […]
The Future of Cell and Gene Therapy
Cell and gene therapies are transforming the course of disease treatment, from gene replacement that extends the lives of infants with spinal muscular atrophy, to CAR T-cell therapies that bring durable remission to patients with difficult-to-treat blood cancers. […]
Summer Partnership Newsletter – The Patient Voice, Clinical Trial Access, New Collaborations & More!
Our Summer Partnership Newsletter explores some of the latest and trending medical education topics like the patient voice in CME, tethered education, the future of gene and cell therapy, improving clinical trial access, results from our recent patient survey and more! […]
Genetic Mitochondrial Disease: Live and On-demand CME Programs Close Learning Gaps
Primary mitochondrial disease (PMD) is often missed by clinicians due to the broad range of clinical presentations and genetic etiologies. Our recent program “Progressive Myopathy: Could it be a Genetic Mitochondrial Disease?” focused on diagnosing this condition in infants, children, and adults who present with progressive muscle weakness; understanding the diagnostic workup; and manifestations of thymidine kinase 2 (TK2) deficiency. […]
The Value of Authentic Patient Voice in Digital Education
Enhancing CME programs with patient voice is an effective strategy for helping providers retain what they’ve learned. National Organization of Rare Disorders Chief Medical and Science Officer Edward Neilan, MD, PhD noted, “when it comes to educational materials, hearing from the patient makes it much more memorable, much more engaging, and a longer lasting educational contribution.” […]
2022 ASCO Annual Meeting Supplemental Digital Oncology Resources
The 2022 ASCO Annual Meeting is a place where cutting-edge research spanning all major disease sites comes together so leaders in the field can stay up-to-date on clinical trials, the latest findings, and global perspectives on oncology innovations. We are especially excited to have two accepted e-abstracts at the 2022 ASCO Annual Meeting that demonstrate the […]
Nurse Spotlight: Improving Clinical Trial Access with LLS Pediatric Nurse Navigator Kelly Laschinger
Researching clinical trials is a formidable challenge. Figuring out which trials offer the most promise to a particular patient is a monumental job, with life-altering implications. With hundreds of thousands of registered clinical trials across the country, it’s no wonder most people are overwhelmed at the prospect of it all. […]
Survey Shows Patients & Caregivers Find Disease-state Education Empowering
A detailed survey of PlatformQ Health (PQH) digital education attendees found patients and families are realizing meaningful changes as a result of the learnings they gained during these programs. […]
AMDF Partners with PlatformQ Health to Bring Impactful, AMD-related Digital Education to Providers and Patients
The American Macular Degeneration Foundation (AMDF) and PlatformQ Health have forged an exclusive education partnership. Together, the organizations will deliver cutting-edge, deployable information about macular degeneration to providers, patients, and their families. […]
Presenting Educational Outcomes at the 25th Annual Meeting of the ASGCT – Changing Care Delivery
Carole Drexel, PhD, Medical Director & Vice President of Patient Education will present a poster at the 2022 ASGCT Annual Meeting at 5:30PM in Hall D, demonstrating the ability of digital education to improve healthcare provider (HCP) competency when preparing for a change in care delivery. […]
Powered By Partnerships Infographic – Making a Difference in Healthcare Education
In collaboration with our partner network, we design education that helps clinicians understand diseases and how to communicate with their patients and empowers patients to become more active participants in their care. […]
Presenting Education Outcomes at ASPHO 2022
We’re pleased to share that the conference has accepted our poster abstract “Impact of Patient-Provider Initiative on Treatment of Pediatric Neuroblastoma” at the 2022 American Society of Pediatric Hematology/Oncology (ASPHO) Conference brings together hematology/oncology professionals for premier education and networking. […]
ASGCT Partners with PlatformQ Health to Bring Impactful, Timely Gene and Cell Therapy Digital Education to Providers and Patients
May 3, 2022 – The American Society of Gene and Cell Therapy (ASGCT) has formed a strategic alliance with the digital technology and education company PlatformQ Health to deliver in-depth digital education programs for clinicians as well as patients and families. […]
CME Program Closes Critical Knowledge Gap in Cancer Immunotherapy Treatment
The initiative succeeded in improving clinicians’ understanding of topics such as biomarker testing, combination therapies, checkpoint inhibitor use, adverse event management, and more. […]
2022 Alliance Industry Summit Supplemental Digital Resources
Poster Presentation The Power of Education to Debunk Myths and Misconceptions about Clinical Trial Participation Among People with Diverse Racial and Ethnic Backgrounds The 2022 Alliance Industry Summit (ASI) will feature our poster about the power of education to debunk myths and misconceptions about clinical trial participation among people from diverse racial and ethnic backgrounds. […]
A collaborative approach to digital neurology education
Together with leading advocacy organizations, we’ve created unique learning channels that help make a difference in the lives of patients with conditions such as multiple sclerosis, dementia, and many other neurological conditions. […]
Presenting Educational Outcomes in Migraine, SMA and Insomnia at AAN
PlatformQ Health is proud to be presenting three posters in Migraine, SMA and Insomnia at the American Academy of Neurology’s Annual 2022 Meeting. […]
A True Champion: A conversation with powerhouse Ricki Fairley
Hear from 10-year cancer survivor, influential advocate and TOUCH CEO, Ricki Fairley, as she dispels myths around clinical trials and discusses how to drive more equitable trial enrollment. […]
CME Palooza Spotlight: Equity in Clinical Trials Is Within Reach: Patient Voices in Medical Education Matter
In our latest collaboration with CME Palooza, we hosted a webinar featuring Jeanne Regnante, Chief Health Equity and Diversity Officer of the lung cancer advocacy organization, LUNGevity, Shawn Feliciano, a patient with MS who has participated in clinical trial research and Sapana Panday, Senior Director of Digital Education at PlatformQ Health. During this conversation the […]
Diversity in Rare Disease Clinical Trials: Making meaningful & practical changes
Leaders from the Moffitt Cancer Center, NORD and TOUCH speak on behalf of their organizations about what they are doing in their day to day to make a difference in the lives of Black or other underserved patient populations. […]
Winter Newsletter – Sharing the latest in partnerships news
Education is at the heart of everything — from launching new screening protocols, to releasing new medications, to enhancing patients’ quality of life. As we enter the New Year, our CEO, Robert Rosenbloom took the time to reflect back on 2021 and impact we’ve had on patients, clinicians and caregivers. […]
#ASH21 Day 4 Recap: Presidential Symposium and late-breaking abstracts
As our #ASH21 blog comes to a close, the hematology community has much to look forward to with a plethora of clinically relevant data, emerging novel therapies, a better understanding of mechanisms of resistance that can lead to new therapeutic strategies, and a strong commitment from the leading hematology organization to address disparities and ensure equity. […]
#ASH21 Day 3 Recap: Ensuring health equity & research findings
Day 3 of the ASH Annual Meeting & Exposition kicked off with a continuation of the Diversity, Health, and Equity track, focusing on changing the tide from paternalistic patterns and exclusion of marginalized populations to inclusion of clinical trial design and a “deliberateness” of engaging minority communities from the very start. This important effort to reevaluate the status quo is part of the hematology community’s commitment to ensuring equity and addressing disparities. […]
#ASH21 Day 2 Recap: Research findings, new data and health equity
Read a short recap of insights about day 2 of ASH, the world’s largest professional society committed to conquering blood diseases, ASH. […]
#ASH21 Day 1 Recap: Tackling Health Equity and Highlighting New Research Findings
The first day of the highly anticipated 63rd ASH Annual Meeting & Exposition kicked off with a new track focused on diversity, health, and equity. As the world’s largest professional society committed to conquering blood diseases, ASH is building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences. […]
End of Year Infographic: Empowering patients on their journey to improved confidence and communication
As patients take an increasingly active role in their own care, education plays a central role. Knowledge fosters shared decision making among providers, patients, and their families. We’re pleased to share outcomes from our digital patient education model. Download the PDF version: 2021-Infographic-Patient.pdf Be sure to check out our other End of Year Infographics: […]
End of Year Infographic: Fostering a powerful, patient-centric, continuing medical education model
Tracking outcomes is essential to PlatformQ Health education, both as a means to continually enhance engagement and to assess knowledge gaps that support the development of future programming. We’re pleased to share the most significant outcomes across our CME programs and their impact on clinical practice and patient outcomes. Download the PDF version now: […]
A patient-centric education model in 2021 and beyond
Education is at the heart of everything — from launching new screening protocols, to releasing new medications, to enhancing patients’ quality of life. […]
Addressing the gulf between patient and provider perspectives
Tethered education: Aligning patients and providers What spurs patients to choose one treatment option over another? What are the hurdles patients face when presented with a newly FDA approved drug? What barriers to change keep physicians from prescribing new treatments? The practice of shared decision making can help answer these crucial questions. This approach can […]
Shortening the Diagnostic Odyssey
Clinicians are facing challenges with diagnosing a wide range of conditions. […]
CME Improves Clinicians’ Knowledge of Tailored Cancer Treatment
After the CME session, 74 percent of learners reported that the activity positively impacted their clinical practice while 61 percent of learners reported that the activity positively impacted patient experiences and outcomes. […]
CMSC 2021 Annual Meeting: Tethered Education Bridges Knowledge Gaps in Multiple Sclerosis
Through tethered education PlatformQ Health sought to address educational gaps around understanding treatment options, side effects, side of disability progression, and strategies to manage functional losses. […]
Society of Paediatric Oncology Congress: PlatformQ Health and Pediatric Oncology Partners Tackle Clinician Knowledge Gaps in Pediatric Neuroblastoma
PlatformQ Health teamed up with Advances in Neuroblastoma Research Association and Solving Kids’ Cancer to develop two one-hour CME programs for clinicians, patients, and caregivers. […]
NORD Rare Summit 2021: Demonstrating the Need for Education in Rare Conditions Among Providers and Patients
For many people suffering from rare diseases, the diagnostic odyssey is far too long. Nearly 1 in 13 people are living with an undiagnosed condition, and it typically takes five years or longer to receive the correct diagnosis. Consistent clinician and patient education about rare diseases is crucial for helping to reduce time to diagnosis […]
Setting the Industry Standard for Education Outcomes: 2021 Conference Recap
PlatformQ Health regularly tracks the outcomes of its CME courses, and publishes these to share with the medical community. […]
American Society of Retina Specialists 39th Annual Scientific Meeting: Anti-VEGF training shows improved patient experiences
PlatformQ Health is presenting an outcomes poster at the American Society of Retina Specialists 39th Annual Scientific Meeting on the impact of targeted online education. […]
Sharing the latest in partnership news at PlatformQ Health
We would like to share some of our latest initiatives, programs, and collaborations, all made possible by our partner network. […]
Promoting Equity in Lung Cancer Clinical Trials
New collaborations are bringing innovative approaches to patient outreach and education to address diversity in clinical trials. […]
Rare Disease Digital Education Infographic
A year-long initiative to produce rare disease digital education made a positive change on clinical practice and patient outcomes. […]
Alliance Connect: Sharing the latest insights on measuring health outcomes & accounting for social determinants of health within CPD design
PlatformQ Health is proud to be a platinum sponsor at the 2021 Alliance Connect conference and will be sharing some of the latest insights on measuring health outcomes & accounting for social determinants of health within CPD design. […]
Outcomes from HER2/HER3 Targeted Therapies CME Series Shared at ASCO 2021
Some of the most important outcomes from the two-part activity highlight clinician barriers to practice in treating HER2/HER3 Metastatic Breast Cancer. […]
Rare Cancers Summit Highlighted in ASCO 2021 Abstract
Abstract highlighting the impact of a new annual digital conference featuring the latest medical education from top experts on rare blood disorders, leukemias, lymphomas and rare solid tumors accepted at the 2021 ASCO Annual Meeting. […]
Clinician/Patient Tethered Education Initiative’s Outcomes Highlighted in ASCO 2021 Abstract
Stay up to date with the latest oncology research at the 2021 ASCO Annual Meeting and read more about PlatformQ Health’s educational advances in the ASCO abstract library. […]
The Patient Voice: Capturing the patient’s lived experiences in CME changes clinical practice and patient outcomes
The patient voice is the presence of the patients’ lived experiences, values, and preferences in medical education, often in the form of video testimonials. It has the power to spur real change in healthcare by capturing the attention of HCPs and inciting them to make improvements in their practice. […]
Alliance Industry Summit Best in Class 2021 – Awarded for a unique outcomes approach that combined quantitative and qualitative methods to incite real change in healthcare
PlatformQ Health received the Best in Class award at the Alliance For Continuing Education in the Health Professions 2021 Virtual Alliance Industry Summit for the outcomes poster, “Unearthing the impact of Urology education through in-depth, qualitative interviews.” […]
American Academy of Dermatology VMX 2021- Moving the Needle with Virtual Education
An e-poster presentation on CIU education for patients, caregivers and health care providers demonstrates the impact of how virtual tethered education can close educational gaps and improve patient experience. […]
2020 Learnings & Beyond: Insights from industry experts
A pre-recorded, moderated panel discussion featuring stakeholders in CME, patient education, industry, and medical education. […]
2021 AAN Annual Meeting – Presenting the latest outcomes on digital neurology education for patients, caregivers and clinicians
Through survey-based evaluation, the poster authors identified educational gaps that will fuel the future learning objectives and topics covered in new and upcoming educational initiatives. […]
Our Commitment to Strategic Partnerships
From subject matter expertise to community engagement strategies, our partners are essential to the success of our health education programs. […]
The three questions you should be asking about outcomes
With more opportunities than ever to reach learners online, it’s important for medical teams to evaluate how online CEs are meeting goals. […]
PlatformQ Health presents e-poster presentation on SMA at the Rare Disease Day at NIH 2021 virtual event
Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and highlights the recent research collaborations to address challenges and advances in new treatments. […]
World Rare Disease Day – Sharing our digital program library with the rare disease community
Together, over the years, NORD and PlatformQ Health have closely collaborated to produce a multitude of digital resources for healthcare professionals, patients, and families to facilitate timely diagnosis and improved care. […]
A Changing World: A Look Back on 2020
In 2020, PlatformQ Health’s mission to improve health outcomes through trusted digital education did not waver. We are grateful to be a steady hand for our partners, HCP and patient learners, and supporters, providing continuity through seamless shifts into the digital world. Digital education is at the heart of our past and current success, and our ability to adapt and innovate is a critical component of our future-focused orientation. […]
NORD, FDA, and CDC Leaders Provide Rare Disease Community COVID-19 Vaccine Education Leveraging PlatformQ Health’s CONDUIT Solution
While the COVID-19 pandemic has been socially and economically devastating for us all, the rare-disease community faces a unique set of challenges. Seeking to address these challenges, the National Organization for Rare Disorders (NORD) leveraged Conduit – PlatformQ Health’s proprietary engagement platform – to host the webinar, COVID-19 Vaccines Update: FDA and CDC Leaders Address the Rare Disease Community. […]
PlatformQ Health, the American Migraine Foundation and the National Headache Foundation collaborate on a new tethered digital educational program
PlatformQ Health is launching, “Aligned Health Care Provider and Patient Education on Calcitonin Gene-Related Peptide-Targeted Treatment of Migraine,” a new digital tethered education program, produced in collaboration with the American Migraine Foundation and the National Headache Foundation on January 22, 2021. […]
Digital health education in 2021: Driving impact through purposeful design
Our world will be different in 2021 and beyond. The question is, how will we, as a health education community, evolve? Here we are, finally, in 2021. For months we looked forward to turning a new year and imagined life where we are not jumping from crisis to crisis—put simply, life that just feels normal. […]
PlatformQ Health ends 2020 with 15 new digital education programs in 5 different therapeutic areas
PlatformQ Health celebrates a busy end to 2020 with 15 digital programs in the month of December, including both accredited online healthcare provider activities and patient education sessions. […]
2020: A year of innovation
From patients to caregivers, associations to pharmaceutical companies, COVID-19 ignited transformative digital innovations across healthcare. Robert Rosenbloom, our CEO, reflects on 2020 and looks to the year ahead. […]
Tethered education: Closing the gap between patients and providers
Under normal circumstances, managing a complicated health condition can be challenging enough with limited in-person time. Now with COVID-19, doctors are scrambling for new strategies to provide care to their patients, leading to a dramatic increase in the reliance on telemedicine. One solution gaining traction: Tethered education. […]
PlatformQ Health launches 4-part clinician online education series on strategies to adapt eye care during COVID-19
PlatformQ Health partnered with the American Macular Degeneration Foundation, Opthalmology360, and BroadcastMed to produce a 4-part CME activity. […]
First-Ever Digital Rare Cancer Congress Benefits Clinicians from Across the United States
The digital Rare Cancer Congress, held on October 28th and November 12th, engaged community-based clinicians and oncologists in 2 focused tracks on rare hematologic malignancies and rare solid tumors which encompassed 9 interactive, expert-led discussions. […]
PlatformQ Health publishes three abstracts in the American Society of Hematology’s Issue of “Blood”
PlatformQ Health Education is pleased to announce the publication of three of our outcomes-evaluation abstracts in conjunction with the upcoming 62nd American Society of Hematology (ASH) Annual Meeting and Exposition. […]
Spotlight on Rare Cancers: Advancing Novel Therapy and Patient Centered Management
PlatformQ Health and the National Organization for Rare Disorders produce 9 rare disease-focused virtual clinician education activities. […]
PlatformQ Health Education, NORD and CureSMA to Co-Present on the Impact of Digital Education on Clinicians and Caregivers at NORD’s Rare Disease and Orphan Products Breakthrough Summit
Partners present findings from an outcome-centric joint educational initiative that showcases the impact rare disease education can have on improving health outcome. […]
PlatformQ Health Virtually Presents Outcomes from a Digital Education Program for Clinicians Treating NSCLC with Immunotherapy
Researcher, Wendy Turell, DrPH, Vice President of CME Outcomes and Analytics at PlatformQ Health Education sought to evaluate and address knowledge and competence gaps when using immunotherapies as treatment for patients with advanced Non-Small Lung Cancer (NSLCL). […]
PlatformQ Health to Host the GBS|CIDP Foundation’s 2020 Virtual Summit
PlatformQ Health helps long-term rare disease partner, the GBS|CIDP Foundation, transform their 2020 Summit into an interactive, engaging, virtual event. […]
Interested in Joining Our Team? Check Out Our New Hire Opportunities!
With more than a decade under our belts, PlatformQ Health is the leading provider of interactive online medical education for HCPs, patients, and caregivers. We are proud to be a steady hand for our partners, panelists, supporters, and learners during uncertain times, when the demand for trusted information is so important. We are fortunate to […]
Conference Poster Sessions Online
We leveraged our videobridge technology to give faculty and experts a platform to share insights from the numerous posters accepted, sharing insights from our CME and patient/caregiver activities. […]
PlatformQ Health’s Upcoming Live & Interactive CME Series
PlatformQ Health has and will continue to collaborate with leading member organizations and patient advocacy group partners to create educational CME series that are live, sequential, interactive, and available for HCPs to watch and re-watch on-demand. […]
NORD’s Virtual Conference on PlatformQ Health’s Learning Platform A Success
NORD leveraged PlatformQ Health’s digital learning platform to give their participants a convenient, user-friendly experience that would allow the rare community to connect and learn effectively, like they would have attending their in-person summit. […]
PlatformQ Health E-Poster Presentation – Differentiating GBS and CIDP in the Hospital Setting: Knowledge and Behavior Changes from Continuing Education
PlatformQ Health is excited to share an e-poster presentation that was accepted at the 2020 American Academy of Neurology Annual Meeting. […]
PlatformQ Health’s Article Published in the International Journal of Clinical Practice
PlatformQ Health Education is proud to share that the article “Taking OAB Seriously: A Qualitative Evaluation of Primary Care Education on Overactive Bladder Syndrome Management” is available online, ahead of publication, in the Wiley journal International Journal of Clinical Practice. […]
NORD taps PlatformQ Health to Transition Living Rare, Living Stronger Patient and Family Forum to Comprehensive, Interactive Virtual Event
Rare disease conference to be held online, featuring dedicated tracks patients and families and medical professionals and students. […]
PlatformQ Health Prepares for a Busy Month of Digital Education Programs Produced in Partnership with Top Healthcare Organizations
PlatformQ Health is prepared for another jam-packed month of digital programs, including both accredited online healthcare provider activities and patient education sessions. […]
PlatformQ Health and Susan G Komen® Launch Online Educational Program to Educate and Empower Patients and Clinicians
PlatformQ Health, the top provider of virtual healthcare events partners with Susan G Komen®, the world’s leading breast cancer organization to produce an interactive online health care provider and patient education program. […]
PlatformQ Health Presents Two E-Poster Presentations for the 80th Scientific Session of the American Diabetes Association
PlatformQ Health is thrilled to share two e-poster presentations that will be exhibited at the 80th Scientific Session of the American Diabetes Association (ADA). […]
PlatformQ Health and Leading Medical Partners Present Comprehensive and Diverse Mix of Online Education Programs in June
PlatformQ Health is excited to announce an influx of upcoming June programs including both accredited online healthcare provider activities and patient education sessions produced in collaboration with some of the leading aligned professional organizations, centers of excellence and patient advocacy groups. […]
American Society of Preventive Cardiology and Joslin Diabetes Center Partner with PlatformQ Health Education to Present a New CME
PlatformQ Health Education is excited to present Dyslipidemia, Diabetes, And Cardiovascular Risk: Clinical Strategies and Evolving Treatments, a free online CME session produced in partnership with the American Society for Preventive Cariology and accredited by the Joslin Diabetes Center (JOS). […]
PlatformQ Health Presents an E-Poster Presentation on the Positive Outcomes of Video-Based Patient Education at ASCO’s Virtual Scientific Program
PlatformQ Health is excited to share a scientific poster that showcases the results from the patient and caregiver online educational program, Positive Knowledge and Behavior Shift Following Video-Based Patient Education on Pancreatic Cancer. […]
AAN Annual Conference 2021: Competency and Knowledge of CGRP Blockade in Migraine Therapy -Influence and Continuing Need for Education
PlatformQ Health is excited to share a poster that showcases the results from the continuing medical education (CME) program, CGRP Blockage: The Evolving Landscape of Migraine Therapy, that was accepted at the 2020 American Academy of Neurology (AAN) Annual Meeting. […]
AAAAI & AAD 2020 Annual Meetings: Education on Atopic Dermatitis Activates Knowledge and Behavioral Shifts among Caregivers, Patients and HCPs
PlatformQ Health is excited to share results from an HCP and patient education initiative that were to be presented as two uniquely focused poster presentations at the American Academy of Allergy, Asthma and Immunology’s Annual Meeting and the American Academy of Dermatology’s 2020 Annual Meeting, respectively. […]
Survey Shows HCPs Turning Online for CME: “We must not ignore other medical topics!”
We surveyed more than 200 HCPs to learn more about how they plan on learning in our ‘new normal’ and what information they’re seeking most often now. […]
ONS Annual Congress 2020: Pediatric Care for Patients with High-Risk Neuroblastoma
PlatformQ Health is excited to share a poster presentation that was accepted at the Oncology Nursing Society’s 45th Annual Congress, that shares insights from three online CME programs addressing nursing care for pediatric patients with high-risk neuroblastoma. […]
Digital Education Series for Urologists Amid COVID-19 Addressing Practice Needs
PlatformQ Health is pleased to announce two new programs dedicated to updating health care professionals about telehealth and practice management, both produced in partnership with LUGPA. […]
2020 Doctor Appreciation Day
The PlatformQ Health Team would like to extend our heartfelt gratitude today, on National Doctor’s Day, to the physicians who tirelessly dedicate themselves to the health and safety of their patients. […]
Oncology Resources For HCPs And Patients During COVID-19 Pandemic
PlatformQ Health’s oncology team recognizes your need for information on practice changes to allow you, clinicians on the front line, to continue treating and protecting vulnerable patient populations. […]
Growth in 2020 and New Hire Opportunities
2019 was a big year for PlatformQ Health. Our team is leaning in to deliver on our mission to improve health outcomes through trusted digital education, and last year it paid off, as 2019 saw: Over 100 live and on-demand educational programs More than 9 million patients impacted by our education New collaborations with best-in-class […]
Year-Long HCP and Patient Education Digital Initiative on Pediatric Epilepsies Launches, with Special Focus on Dravet Syndrome from PlatformQ Health
February marks the beginning of a year-long, digital education initiative for HCPs and caregivers with children with pediatric epilepsy, presented in partnership with leading aligned advocacy organizations like the National Organization for Rare Disease (NORD) and Dravet Syndrome Foundation, and more. […]
Understanding hATTR Amyloidosis & It’s Impact on Your Family
We are pleased to announce a new, live video education session for families facing an amyloidosis diagnosis on NeuroCareLive. […]
PlatformQ Health Presents at 2020 Alliance Annual Conference
PlatformQ Health is pleased to announce our team will present two sessions at the upcoming 2020 Alliance Annual Conference January 8-11th in San Francisco, CA. […]
Flu Vaccination: Audience Q&A with CDC
We joined forces with the Centers for Disease Control and Prevention (CDC) to share live education for the public about the 2019-2020 influenza (flu) season, and the importance of flu vaccination. […]
PlatformQ Health & GBS|CIDP Foundation International Release Next Video Education Program
Building on questions received during their first educational initiative for patients and families affected by chronic inflammatory demyelinating polyneuropathy (CIDP), PlatformQ Health and GBS|CIDP Foundation International are today pleased to announce a new video program that will be live on December 11th at 3pm ET on NeuroCareLive. […]
PlatformQ Health to Present Poster at 2019 ASH Annual Meeting
PlatformQ Health will present a poster session at the 2019 ASH Annual Meeting sharing insights from recent CME and patient education activities on Follicular Lymphoma. […]
Tips to Determine if Online Health Information is Reliable
How can you tell if a source of health information is trust-worthy? […]
PlatformQ Health Partner DBSA Launches First-of-Kind Effort in Depression Research
By raising your voice through this unique campaign, you will accelerate progress for more and better options to treat depression and achieve or regain wellness. Join PlatformQ and DBSA in support of better treatment and care for depression by taking action today! […]
Diabetes Tethered Free White Paper
Learn how aligned diabetes education is moving the needle on patient care. […]
NORD Summit 2019: Breakthroughs, Advocates, and Partners
PlatformQ Health was pleased to attend the National Organization for Rare DisordersⓇ (NORD) 2019 Rare Diseases & Orphan Products Breakthrough Summit. […]
Centers for Disease Control and Prevention to Host Seasonal Influenza Education with PlatformQ Health
This year, the Centers for Disease Control and Prevention (CDC) is releasing two educational segments about flu vaccination with PlatformQ Health: one designed specifically for health care professionals (HCPs) and the other for members of the public. […]
Depression and Bipolar Support Alliance Selects PlatformQ Health to Lead New Digital Educational Initiative to Address the Mental Health Crisis
The Depression and Bipolar Support Alliance (DBSA), the leading peer-directed national organization for people living with mood disorders, and PlatformQ Health, a premier provider of digital education for clinicians and patients across the therapeutic spectrum, are pleased to announce a new initiative to elevate the way clinicians diagnose and treat mental illness, and empower the millions of Americans who personally face conditions like depression and bipolar to make the best choices for their lives. […]
Clinical Trials Poster Presentation at ASCO Quality Care 2019
PlatformQ Health is pleased to be able to share outcomes from a recent patient/caregiver program on clinical trials at the ASCO Quality Care Symposium in San Diego, CA this September. […]
New Education for People Who Have Neuroendocrine Tumors
Following two successful programs, produced in partnership with the Carcinoid Cancer Foundation, PlatformQ Health is pleased to announce an all-new program for patients and caregivers on Neuroendocrine Tumors that will premiere live at 1pm ET on August 14, 2019 on CancerCoachLive. […]
Basal Insulins for treating diabetes mellitus, from discovery to modernity
Basal insulin is also referred to as background insulin. It is that insulin which the pancreas produces and is present all the time. […]
NORD Launches Digital Education Initiative with PlatformQ Health
The National Organization for Rare Disorders (NORD)Ⓡ, the leading independent nonprofit organization representing the 25 to 30 million Americans living with rare diseases, is proud to announce it has joined forces with PlatformQ Health, a leading provider of digital education for clinicians and patients, to create accredited online education about rare diseases. Recognizing the need for accessible, engaging and effective digital education on rare diseases, NORD seeks to equip healthcare […]
Aligned Educational Series in Multiple Sclerosis – Live This Summer
PlatformQ Health is pleased to announce a three-part educational series for the clinicians treating and families facing multiple sclerosis (MS), created in collaboration with the National Multiple Sclerosis Society (NMSS) and the Consortium of Multiple Sclerosis Centers (CMSC). […]
PlatformQ Health to Present at Moderated Poster Session at ADA 2019
PlatformQ Health is pleased to announce our education team will present a poster session at the 79th annual scientific session of the American Diabetes Association (ADA). […]
PlatformQ Health Attending ASCO 2019
PlatformQ Health will be in Chicago for the 2019 ASCO Annual Meeting May 31 – June 4 and is pleased to have an abstract accepted for online publication for the 2019 meeting. […]
Neurological Rare Diseases Front & Center in PlatformQ Health Poster Sessions at AAN 2019
PlatformQ Health is pleased to announce our education team will present three poster sessions at this year’s Annual Meeting of the American Academy of Neurology (AAN), which will share insights from recent educational series in neurological diseases, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Lennox-Gastaut Syndrome, and Multiple Sclerosis (MS). […]
Many Milestones for PlatformQ Health and Partners
We deepened relationships and developed content in new spaces with existing partners, and delivered important new clinician education in a broad variety of therapeutic areas. […]
Learning from Patients Yields Better Education on Depression
PlatformQ Health is proud to announce a new video education program for patients with Major Depressive Disorder (MDD), which will premiere live online on March 13, 2019 at 1pm ET on NeuroCareLive.com. This latest collaboration with the Depression and Bipolar Support Alliance (DBSA) follows a successful program last year that featured real patient testimonials, and an expert panel including clinicians and advocacy representatives. […]
#ShowYourRare – Rare Disease Day 2019
On Rare Disease Day 2019, we acknowledge the realities of daily life for people around the world who are managing a rare disease. […]
Overview of hATTR Amyloidosis: New CME
Join our experts for a one-hour CME presentation as they appraise clinical safety and efficacy data for new and emerging therapeutic agents for the treatment of hATTR amyloidosis. […]
Tips to Prepare for Your Doctor’s Visit
Going to see your doctor can be a frightening experience: you may be worried you have a serious affliction, or maybe you’re just going to follow up for a chronic condition, or maybe there is a procedure you are facing that you know will be painful. […]
Overview of Ovarian Cancer: New CME
According to the CDC, ovarian cancer is the second most common gynecologic cancer, comprising 3% of all cancers in women. Approximately 11 out of every 100,000 women are diagnosed with new cases annually (over 20,000), and 7 out of every 100,000 (over 14,000) will die of the disease in the same time period. […]
It’s National Diabetes Month: PlatformQ Health Shares Patient Education to Improve Outcomes
November is National Diabetes Month and PlatformQ Health is excited to support the awareness and empowerment of patients and caregivers managing diabetes by providing them with interactive education. […]
Overview of Overactive Bladder: New CME
Overactive bladder (OAB) is a distressing bladder disorder marked by urinary urgency, frequency, nocturia, and urge incontinence. It often has a negative impact on the quality of life, sleep, sexual function, and mental health. […]
PlatformQ Health Helps DBSA Bring Patient Voice to Researchers and Regulators Supporting Major Depressive Disorders
PlatformQ Health is pleased to support the “Well Beyond Blue” initiative, championed by the Depression and Bipolar Support Alliance (DBSA), which aims to connect people who live with depression with researchers, regulators, and life science companies better understand what it’s like to live with depression and what is most important in terms of better treatment options. […]
PlatformQ Health Presents Poster Session at ASCO Quality Care Symposium 2018
The 2018 ASCO Quality Care Symposium was held on September 28 and 29, 2018 in Phoenix, AZ, and PlatformQ Health was honored to present a poster session on the impact of online patient education for people with bladder cancer. […]
Overview of Follicular Lymphoma: New CME
A new follicular lymphoma CME program worth 1 AMA PRA Category 1 Credits™, is now available on demand. Find it here. In the Western hemisphere, follicular lymphoma (FL) is the most common non-Hodgkin lymphoma (NHL). In the US in 2018, it is expected that approximately 74,680 new cases of NHL will be diagnosed and 20% […]
B-Cell Patient Education Case Study
Learn how live-online video education impacted patient & caregiver knowledge, communication, and behavior. […]
Managing Your Cancer as a Chronic Disease
Current statistics estimate that this year, of the 1,735,350 new cases of cancer that will be diagnosed in the United States, over 1.1 million people will face the challenges of continuing to live a meaningful life with cancer. While everyone has heard about the rigors of and side effects than can accompany cancer treatments such […]
Exploring Our Current Knowledge of the Pathophysiology of Idiopathic Pulmonary Fibrosis: New CME
Find new Idiopathic Pulmonary Fibrosis CME on ResInsightsLive, and a program designed for patients and their families on RareDiseaseLive. Idiopathic pulmonary fibrosis (IPF) is a rare pulmonary disease caused by the formation of scar tissue in the lungs without any known triggering factor. Across the globe, five million people are affected with a prevalence […]
Tips to Manage Your Chronic Disease
You’ve just seen your doctor and they told you that you have a chronic disease, or you’ve been struggling with one (or more) for years now. You may be overwhelmed with the amount of information your doctor gave you about your new disease, or maybe you weren’t given any at all. The doctor may have […]
PlatformQ Health & OMedLive at ASCO 2018
Our commitment to oncology practice and cancer care makes ASCO 2018 one of the most exciting events for our team, because it gives us an opportunity to explain how we’re improving healthcare outcomes through trusted digital education for people with cancer. […]
Carcinoid Syndrome: The Tumor and the Hormones
He lay there in the ICU bed with his family standing by in the waiting area. As the intern on call, I was called to his bedside once again because his blood pressure plunged dangerously low. Unfortunately, his prognosis was poor, in fact terminal. The medical team knew this would be the last time he […]
AUA 2018 Full of New Research, Processes, and Inventions
Jeff Arnold, General Manager at PlatformQ Health, attended the latest meeting of the American Urological Association (AUA) in San Francisco. […]
New Diabetes CME & Education for Patients
On Wednesday, May 9, 2018 from 11:00 AM – 12:00 PM ET, a diabetes CME program about new long acting insulins for the treatment of Type 2 Diabetes will air live on DiabetesSeriesLive. New Long-acting Insulins for the Treatment of Type 2 Diabetes: Data, Guidelines, and Perspectives on Patient and Provider Barriers will cover: • […]
Recent advances in the knowledge of brain pathology in Multiple Sclerosis patients
Multiple sclerosis (MS) is a complicated demyelinating disease of the central nervous system, where patients experience a great range of symptoms due to demyelination of nerve fibers. It is characterized by plaques in the brain and spinal fluid. Symptoms that have been observed include numbness, diplopia, cognitive impairment, paralysis, blindness, fatigue, and bladder dystonia. [1] […]
Rare Disease, Migraine and MS Front and Center at AAN
PlatformQ Health was proud to present two posters – a traditional poster and an e-poster – at this year’s Annual Meeting of the American Academy of Neurology (AAN). Alongside VP of Education Jayne Chaplick, Senior Medical Director Anne Roc attended to present the posters, which focus on insights from previous PQH educational initiatives. […]
CMEpalooza 2018: PlatformQ Health Presents on Partnering with Patient Advocacy Groups
The Spring session of CMEpalooza featured two full days of live programming designed for the continuing medical education community. This year, PlatformQ Health (PQH) sent two delegates to the session titled Including Patients and Patient Advocacy Groups in Educational Planning & Delivery: How to Make It a “Win-Win”. Senior VP of Education, Kathryn Pucci, acted […]
Peer Reviewed Publication in the Health Education Journal on B-cell NHL Patient Education
PlatformQ Health is pleased to announce the Health Education Journal, a peer reviewed journal focusing on the contributions that health education can make to personal and social well-being, health promotion and individual and public health, has published an article on a recent Platform Q Patient Education (PQPE) program for people with B-cell NHL. […]
PlatformQ Health to Receive Best in Class Outcomes Award at Alliance Industry Summit
PlatformQ Health will present a poster at the Alliance Industry Summit (AIS) 2018 “Best in Class Outcomes Awards” Monday, May 7, 2018 highlighting a series of diabetes programs for clinicians created in collaboration with the renowned Joslin Diabetes Center. […]
Taking Control of Your Diabetes by Monitoring Your Blood Sugar at Home
Most patients with diabetes end up with a glucometer for testing their blood sugar at home. However, I frequently find that many of the patients I see did not receive instructions on how or when to check their sugar, or what to do with the results when they have them. Of course, the answer to […]
Two Neurology Patient Poster Sessions to be Presented at AAN 2018 Annual Meeting
PlatformQ Health is pleased to announce our education team will present two poster sessions at the 2018 Annual Meeting of the American Academy of Neurology April 23 and 24 in Los Angeles, California. […]
Ground-Breaking PRECISION Study Results: MRI Superior for Prostate Cancer
Currently, the guidelines around prostate cancer for physicians like me follow are murky, and best practices are subject to debate by different medical organizations. A widely-known recommendation called a PSA (Prostate Specific Antigen) screening, for example, has been fraught with failings and blamed for causing an unacceptable number of unnecessary prostate biopsies. On March 19, […]
PlatformQ Celebrates National Physicians’ Week
March 25 through March 31 marks National Physicians’ Week, a time dedicated to recognizing and thanking doctors for the sacrifices they make to take care of all of us. Doctors work tirelessly to help people when they are most in need, and in spite of the important role they play in our lives, they often […]
Tips to Prevent Prediabetes from Turning into Diabetes
While much research is being conducted into rising rates of diabetes mellitus around the globe, in the US an approximate 85 million people have prediabetes. Prediabetes is a condition where a person’s blood sugar is elevated outside the normal range but do not meet the criteria for diabetes. It is very important to identify these […]
Prostate Cancer Tests: How to advise patients when recommendations disagree
What do doctors need to know about prostate cancer and the tests used to diagnose it? According to the American Cancer Society, who offer the most recent data regarding cancer statistics in the U.S., an estimated 161,360 men were newly diagnosed with prostate cancer in 2017. In the same time period, over 26,000 men died […]
Upcoming Clinician Education on New Abuse-Deterrent Formulations in Pain Management
Log into PainCareLive on Tuesday, March 13, 2018 at 2:00 PM ET for a live online CME Certified activity discussing the safety, efficacy, and tolerability profiles of abuse-deterrent opioid formulations and their potential to reduce opioid misuse/abuse in treating patients with acute or chronic pain. This accredited program, Targeting Opioid Misuse: Abuse-Deterrent Formulations in the Management […]
The Struggles of Being Diabetic
Please join DiabetesCoachLive for a special program designed for diabetic people and their loved ones. Patients and experts from Joslin Diabetes Center will be walking through insulin options, debunking myths about side effects, and answering questions from the audience. Watch on demand now >> When people think of diabetes, their mind immediately jumps to […]
Women who Have Changed the Course of Medicine
Today, medical school enrollment is nearly equivalent between men and women across the country – but most women physicians still believe that disparities exist between male and female doctors due to personal experience and staggering gender differences in medical leadership. While 73 percent of health service and medical manager jobs are held by women, only […]
Rare Disease Day 2018
World Rare Disease Day is celebrated on the last day of February each year (often February 28, “rarely” on leap day). Since 2008, this day has grown into a global initiative involving more than 90 countries and hundreds of cities to raise awareness of rare diseases and encourage researchers and leaders to address the needs […]
VP of Digital Education, Jayne Chaplick, On the Meaningful Inclusion of Patients at Alliance 2018
The biggest yearly gathering in CME, the Alliance Annual Conference, just wrapped up in Orlando, Florida, after several engaging days of programming around the theme Destination: Patient Outcomes. Our Journey to Improving Patient Care. Several members of the PlatformQ Health Education (PQH Education) leadership team were in attendance, and we were happy to be able […]
Expert-led Roundtable on Heart Failure: Part 2 Airs Live on February 9
On February 9, 2018 at 10:00 am EST, join CardioCareLive for a roundtable discussion on the new guidelines for the treatment of heart failure. In this second part of our series on Implementing Guideline-Directed Medical Therapy for Patients with Heart Failure, the panelists will discuss multidisciplinary approaches to implementing the guidelines – specifically, the challenges […]
Upcoming Live Programs on the PlatformQ Health Network: February 2018 Edition
February is shaping up to be a busy time on the PlatformQ Health network. This month’s live broadcasts include a panel discussion on the new Heart Failure Guidelines and information about the latest treatment strategies for schizophrenia, as well as programs with Association of Community Cancer Centers (ACCC) and Depression and Bipolar Support Alliance (DBSA) […]
PlatformQ Health’s Senior VP of Education, Kathy Pucci, Reflects on Alliance 2018
PlatformQ Health Education (PQH Education) was proud to send several delegates to the 2018 Alliance Annual Conference January 21 and 22 in Orlando, Florida. The Alliance Annual Conference is the largest gathering in CME, and this year’s theme was Destination: Patient Outcomes. Our Journey to Improving Patient Care. In addition to presenting two sessions and […]
Exploring the Increased Mortality Rate in Schizophrenia
Schizophrenia is a mental health disorder that is chronic and disabling and affects the way a person thinks, feels, and behaves. Typically, symptoms start between the ages of 16 and 30; rarely it is observed in children as well. Symptoms of this disease are categorized into 3 types – positive, negative, and cognitive: Positive symptoms: These […]
PlatformQ Health Education and the American Academy of Family Physicians (AAFP) to Host Live Online Education on Major Depressive Disorder (MDD)
PlatformQ Health Education, in joint providership with the American Academy of Family Physicians (AAFP), announces the first of two online educational programs on shared decision making in major depressive disorder (MDD) treatment. Major depressive disorder (MDD) has substantial negative effects on patients’ functional abilities and quality of life. This tethered, or mutual, education will focus […]
Wendy Turell to Receive Alliance Leadership Award at 2018 Alliance Annual Conference
Please join us in congratulating Wendy Turell as she receives an Alliance Leadership Award in recognition of her service and direction as Chair of the Alliance Research Committee. The Opening Night Awards Dinner will take place January 20th from 5:30 – 7:30pm, kicking off the annual conference with a celebration of the education industry and […]
Online Patient Education Drives Meaningful Outcomes
The inaugural program for CancerCoachLive, PlatformQ Health’s educational channel for online patient education about different forms of cancer, was launched in 2016 through a partnership with The Leukemia & Lymphoma Society (LLS) focusing on educating patients with B-cell non-Hodgkin lymphomas (NHL). Building on LLS’s goal to empower patients through education, this program aimed to improve knowledge […]
PlatformQ Health at the Alliance Annual Conference
PlatformQ Health Education (PQH Education) is pleased to announce we will be presenting two sessions at the upcoming 2018 Alliance Annual Conference January 21 and 22 in Orlando, Florida. The Alliance Annual Conference is the largest gathering in CME, bringing together professionals in continuing healthcare education from across the spectrum of organization settings. These […]
Addiction and Pain Medicine Specialists Disagree on Addressing Opioid Abuse
Healthcare professionals and policymakers are struggling to come to terms with the epidemic of opioid abuse and overdose in the United States – perhaps nowhere more than here in Massachusetts, where the presence of premier medical institutions has not been able to stem the state’s record high rates of opioid-overdose deaths (which are among the […]
A Review of Acute Myeloid Leukemia (AML)
Acute myelogenous/myeloid leukemia (AML) is one of the malignant diseases of the bone marrow. In this disease, hematopoietic precursor cells become arrested in early stages of development. Typically, AML is distinguished from other blood disorders by the presence of greater than 20% blasts seen in the bone marrow. AML has many names including acute myelocytic […]
Congestive Heart Failure 2016
Our understanding of congestive heart failure has been rapidly evolving over the past decade. Heart failure is a leading cause of mortality globally and in the US. It is the final end-point of various cardiac diseases. When the cardiac muscles fail, hypertrophy of the cardiac muscle cells is commonly observed. This hypertrophy of cardiomyoctes is […]
To Mammogram or Not To Mammogram: The Deadly Debate Continues
The patient sitting on the exam table was happy to be diagnosed with breast cancer. That may seem unbelievable, especially for a 41 year old mother of young children. However, she was lucky to be screened. She is of the age where current controversy exists whether she should have an annual mammogram or not. Fortunately, we […]
New Live Programs Across the PlatformQ Health Network
In the next two weeks, we’ll be presenting 7 new educational programs on 9 topics across the PlatformQ Health network. With over a dozen therapeutically aligned channels for you to learn from, odds are we’ve got some easy, convenient online CME/CE for you to check out. And with almost all of our programs produced and […]
Seasonal Allergies: Focus on Allergic Rhinitis
Allergic rhinitis (AR) is one of the major symptoms of seasonal allergies. When the nose is exposed to an allergen, an Ig-E mediated response ensues. Characteristic symptoms include watery rhinorrhea, nasal obstruction, nasal itching, and sneezing. In the US, approximately 60 million people suffer from AR or 10-30% of the adult population and 40% of […]
Male Breast Cancer: Being a man with a “woman’s disease”
The reality of male breast cancer This year, like past years, over four hundred men in the US will die from breast cancer. Despite this fact, many people are unaware that men can even develop breast cancer. While advocates have done a great job raising awareness for breast cancer, men are still largely ignored in […]
Tick-Borne Diseases: Tick Paralysis
Across the globe, there are more than 40 species that cause tick paralysis. While only five of those species live in North America, the common deer tick is one of them and is found in any area where there are ticks. In the US, thousands of livestock and domestic animals have been killed by tick […]
Eight Myths About Vaccines that Still Worry Parents
From government conspiracies to autism, vaccine outreach programs have been repeatedly called into suspicion. The long-circulating myth that vaccines cause autism, for example, resulted from research published in The Lancet, one of the world’s oldest and best known general medical journals, and while the author of that research was later found to have fabricated his […]
Geographic Atrophy and Age-Related Macular Degeneration (AMD)
Age-Related macular degeneration (AMD) is one of the most common causes of visual loss in the US. During later stages, visual acuity is worsened due to choroidal neovascularization (CNV) and geographic atrophy (GA). GA occurs when dry AMD becomes advanced. In early dry AMD, protein deposits, called drusen, are seen scattered on the retina, which […]
The Battle Is On: Humanity vs. Pathogens in the Age of Antibiotic Resistance
In the twentieth century, one of the greatest weapons in the war against infectious diseases was created: antibiotics. With this powerful scythe of medicine, bacteria were decimated and humanity slowly gained control over the battlefield. Bacteria lost its killing power and humans lived to older ages. In fact, bacteria’s virulent characteristics were suppressed and they […]
Pseudobulbar Affect (PBA): Diagnosis in the Midst of Depression
Pseudobulbaa affect (PBA) typically presents as episodes of uncontrollable laughing or crying that is out of context to the current social situation. The patient’s emotional expression is incongruent to their emotional state. Usually, PBA is seen in the setting of other neurologic diseases such as ALS, Parkinson’s disease, Alzeihmer’s dementia, stroke, progressive MS, brain tumors, […]
2017 ASCO Annual Meeting Abstracts for Publication
We’re proud to have 4 abstracts accepted for publication for the 2017 ASCO Annual Meeting. Educating oncologists and empowering cancer patients in the 21st century means delivering precision education that supports precision medicine. […]
Going to 2017 ASCO Annual Meeting? Come see us!
OMedLive, an online oncology learning channel of PlatformQ Health Education, will be in Chicago for the 2017 ASCO Annual Meeting next week. Our commitment to oncology practice and cancer care makes this one of the most exciting events for our team, as four of our fifteen therapeutically-aligned learning channels are closely tied to the core […]
PCSK9 Inhibitors and Their Role in Lipid Management
The discovery of the relationship between lipids and cardiovascular disease was first made in the 1960s. Following this, an urgent need was filled by the founding of lipid lowering medications, with statins being the gold standard of therapy. However, the consequences of lipid disorders and cardiovascular disease remain prevalent despite this knowledge. Patients with familial […]
The New Tick-Borne Disease on the Block: Powassan Virus
Powassan virus (POW) is a flavivirus transmitted through tick bites, first discovered in the town of Powassan, Ontario in 1958 when it was identified in a young boy. This virus is transmitted more rapidly from tick to human than Lyme disease (it can take only minutes) and more likely to be fatal. As of […]
PlatformQ Health Education to Present at AIS 2017: Inclusion of the Patient Voice
PlatformQ Health Education (PQH Education) is pleased to announce that we will be presenting a Lightning Round session at The 2017 Alliance Industry Summit (AIS 2017) May 22-24, 2017 in Philadelphia, PA. […]
Tick-Borne Disease: Update in Lyme Disease
Sitting around the table with my medical students discussing our recently diagnosed child with Lyme disease, our discussion focused on the need for early diagnosis. While this particular patient was caught fairly early in her disease based on symptoms, the diagnosis remains elusive for many. Blood tests do not detect early stages of the disease […]
How to Enjoy the Outdoors without Getting Lyme Disease
Lyme disease is a bacterial (Borrelia burgdoferi) infection transmitted to humans through the bite of an infected black-legged tick, most commonly the deer tick. Because they are so small (about the size of a pin head), they often go unnoticed on the body. In order for Lyme disease to be transmitted, they must be attached […]
PlatformQ Health Education to Present at the Quality and Innovation Summit
PlatformQ Health Education (PQH Education) is pleased to announce that we will be presenting a session at The 2017 Alliance Quality and Innovation Summit September 25-27, 2017 in Park City, Utah. The session, titled Investigating the Impact of Patient Education on Self-Efficacy and Health Communication, will be presented by Wendy Turell, DrPH, VP of CME […]
Alzheimer’s and its Neuropsychiatric Relationships: Focus on Depression
Did you know there is a relationship between Alzheimer’s & depression? In the US, Alzheimer’s Disease (AD) is the sixth leading cause of death with greater than 5 million people currently living with the disease. Since the year 2000, deaths from cardiovascular disease have decreased by 14% while there have been an 89% increase in deaths caused […]
Rare Diseases: Why We All Need to be Aware
While rare diseases are uncommon, there are a multitude of them. In the US, there are approximately 7,000 diseases that are considered to be rare. It is approximated that there are nearly 300,000,000 patients around the world who are diagnosed with a rare disease. In the US, a rare disease is defined as any disease […]
Basal Insulin: treating diabetes mellitus, from discovery to modernity
Basal insulin is also referred to as background insulin. It is that insulin which the pancreas produces and is present all the time. In contrast, bolus insulin is the extra amount of insulin the pancreas produces in response to glucose intake. In patients with T1DM, the pancreas stops making insulin and the patient needs to […]
Pancreatic Cancer: How Long Will it Remain “Incurable”?
As medical students and residents, we were taught to fear pancreatic cancer. As most people know, the cure rate is dismal and the majority of victims die within the first year of diagnosis. While this has been improving over the past years, the low five year survival rate persists. According to the American Cancer Society, […]
Colorectal Cancer Around the Globe
Colorectal cancer is one of the most common cancers in the US, as well as around the world. Additionally, it remains one of the leading causes of cancer deaths as well. Our knowledge of this deadly disease increased exponentially in recent years and we now have screening tests and a plethora of treatment modalities. Yet, […]
Zika in 2016: A timeline in the battle of Zika virus around the world
Much speculation filled the news about Zika virus over the past year. We watched as news filtered out from Brazil and other countries about the increasing incidence of microcephaly in newborn babies from mothers who were infection with the virus. And, as fears mounted, we witnessed its arrival in the US. What is Zika? Zika […]
The American Opioid Epidemic: Where We Stand In 2016
According to statistics compiled from the CDC, more than 165,000 people in the US died as a result of overdoses due to prescription medications from 1999 to 2014. The rate continues climbing with over 14,000 deaths in 2014 alone. While death is the most dangerous end-point, that is just the tip of the iceberg. It […]
Diabetes Mellitus and motivational interviewing
Motivational interviewing is a form of counseling developed by William R. Miller, PhD and Professor Steven Rollinick in 1983. First devised to help in the treatment of alcoholics, motivational interviewing can serve as a framework for evoking any motivation to change and has been used for many conditions including substance abuse, smoking, obesity and diabetes. […]
Metastatic Colon Cancer Can be a Preventable Disease
Colorectal cancer is the third leading cause of cancer death in the US. The American Cancer Society (ACS) reported that there will be over 95,000 new cases of colon cancer and over 39,000 cases of rectal cancer in the US in 2016. Men have a 1 in 21 lifetime risk of developing colorectal cancer whereas […]
Crohn’s Disease Patient Story: Over 250 hospitalizations
Crohn’s disease is still a challenge to diagnose and treat. Crohn’s disease is a form of inflammatory bowel disease that can create issues in the small intestine and, less frequently, in the large intestine. It is often painful and can lead to life-threatening consequences. While most symptoms are gastrointestinal in nature, it can also be […]
Medical Highlights of 2016: The Good and the Bad
2016 saw many changes happening in the medical arena; some good, some bad, and some just interesting. Many familiar characters played a role on the medical stage, more observed quietly, and some new voices rang out expressing what needs to be fixed and where medicine should journey. A look back at medical highlights of 2016 […]
Cases, Challenges, and Controversies on High-Risk Pediatric Neuroblastoma
This OMEDLIVE presentation is Part Two of a two-part series surrounding Pediatric Neuroblastoma. During the conversation, Dr. Jason Shohet and Jennifer Saggio, MSN, CRNP, CPON focus on the following areas: Overview of pathology and standard therapy for high-risk NB Required imaging and evaluations for the revised INRGSS system Overall treatment scheme, including recent proposed changes […]
Lung Cancer Immunotherapy CME: Shifting the Lung Cancer Treatment Paradigm
A recap of OMedLive’s online lung cancer CME program, Immunotherapy: Shifting the Lung Cancer Treatment Paradigm, which aired live on November 3rd, 2016. According to the American Cancer Society, lung cancer is the leading cause of cancer deaths in most countries. In 2015, the US saw 221,000 new cases of lung cancer (13% of all […]
Crohn’s Disease: It is not Just Another GI Disorder
Crohn’s disease is an inflammatory bowel disease that was first described by Dr. Burrill B. Crohn in 1932. Ulcerative colitis is another inflammatory and while the symptoms between the two are similar, it is important to make a distinction between the two. Crohn’s Disease most commonly affects the ileum and proximal colon but can affect […]
Does the CDC have More Effect Globally than in the US?
One of the greatest advancements in medicine came with the advent of the vaccination program. Certain diseases, such as small pox, were eradicated around the globe through aggressive vaccination programs by both the CDC and the WHO. Other diseases like Polio no longer exist in the Americas and others are in the process of being […]
The Evolving Genesis of Obesity
Over the past many years or decades, people believed that obesity was caused by a misbalance of calories: obese patients consume more calories that they expend. While this is true in many cases, it is not the complete picture. Recent research is discovering a whole host of causes that contribute to obesity and it is […]
SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes: Methodology and Monitoring Impact
In this CME offering presented by the Primary Care Network and Diabetes Series Live, Drs. Richard Beaser, Associate Professor of Medicine and Harvard Medical School and Nuha El Sayed, Director of International Programs at Joslin Diabetes Center introduce and educate viewers on a relatively new class of drugs to combat Type II Diabetes; the SGLT-2 […]
Diabetes Injectables Reference Chart for Clinicians
Our medical directors compiled this clinical reference chart for injectables used to treat diabetes. It is current as of September 2016, and lists the class, onset, dose and peak for each medication. Physicians, nurses and other health care providers can refer to the digital chart or print the two-page pdf for wall posting. To find […]
Concussion in Children: Returning to Play
In my practice, I see it frequently that a coach allowed a patient to return to play after suffering a concussion and still symptomatic. The popular movie, “Concussion” starring Will Smith, brought to light the grave damage recurrent concussions can cause on the brain to the general American population. Yet, for some, the future neurological […]
The Genetics of Lung Cancer
Everyone is aware of the link between cigarette smoking and lung cancer. However, recent research is showing strong genetic contributors to the development of these cancers. Even among smokers, genetics appear to play some role. Not every smoker develops lung cancer and not everyone who develops lung cancer smokes. Here, we’ll review the genetics of […]
GASTRIC CANCER: A GLOBAL VIEW
Gastric cancer, also known as stomach cancer, remains an aggressive cancer around the globe. Over the past several decades, there has been a slight decrease in incidence, yet it remains the fourth most common cancer and the second deadliest across the world. Some factors that are thought to be responsible for the declining incidence include […]
Breast Cancer in Men: Where we are in 2016
While everyone is aware that breast cancer in woman exists, many do not know men can be similarly afflicted. Breast cancer in women has its own awareness month (October) and its own symbol of awareness, the pink ribbon. Breast cancer in men, on the other hand, do not even have treatments tailored to them but […]
Rare Disease Information Sources for Primary Care Providers
Based on a survey conducted in January 2016, the Association for Comprehensive Care in Rare Diseases (ACCORD) published two white papers on primary care medicine for patients living with a rare disease. The first paper, based on a survey of 536 primary care providers (PCPs), and described in a previous blog post, concluded PCPs lacked […]
CDC Zika Update: Joanne Cono, MD ScM Clinical Session
Zika Virus is in the news, people are concerned about this epidemic expanding through the U.S. protectorates and threatening the continental U.S. and Hawaii. We’re at the early stages of understanding this virus and there is much misinformation and uncertainty surrounding this new global pathogenic threat. While the anxiety is wide-spread, the Center for Disease […]
Zika: CDC updates clinicians on Zika Virus
Zika, already a problem in Puerto Rico, American Samoa, and the U.S. Virgin Islands, should reach the mainland U.S. as seasonal temperatures climb and the mosquito responsible for transmission becomes active. To date, there have been 273 travel-associated cases of Zika in U.S. States, 19 are in pregnant women and six were sexually transmitted. In […]
Rare Diseases and How Primary Care Physicians Can Work with Patients
The Association for Comprehensive Care in Rare Diseases (ACCORD) recently conducted a novel survey around primary care in patients with rare diseases. To better understand physicians’ viewpoint on the topic, the team at ACCORD conducted a survey of 536 clinicians who reported having at least one patient in their practice who received care from […]
The Advancement of Biosimilars: A New Frontier in Medicine
In this recent CME offering from ClinicalSeriesLive, “The Advancement of Biosimilars: A New Frontier in Medicine, Clinical Applications and Concerns Regarding Biosimilar Products,” viewers gain valuable insight into the testing, approval, and use of biosimilars or treatment of various diseases. As of the production of the video, the only biosimilar approved by the FDA is […]
Treatment Options for Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL) is the most prevalent type of adult leukemia, with a median age of diagnosis of 72. However, 10 percent of patients are under age 50, twice as common in men as it is in women. There is a genetic predisposition; an environmental predisposition is uncertain, although Vietnam Veterans with Agent Orange […]
Clinical Spotlight on Novel Treatments for Heart Failure
Editor’s note: This article on new treatment options for heart failure also applies to HCPs caring for patients living with diabetes. Our sister site, CardioCareLive.com, hosted this online CME session. In the United States there are about 5.7 million people diagnosed with heart failure (HF), most of them female. With 870,000 new HF patients diagnosed annually, the 2012 […]
Pediatric Epilepsy: From early childhood through adolescence
In this CME offering from NeuroSeriesLive, Dr. Dennis Dlugos takes viewers through the current best practices for pediatric epilepsy. Using two case studies, Dr. Dlugos discusses diagnosis challenges and considerations, goals and concerns of medication treatments, and offers several non-medical treatment options. Dr. Dlugos, Professor of Neurology and Pediatrics at the Perelman School of Medicine […]
2016 Screening Guidelines for Type 2 Diabetes
The ADA and AACE just jointly released 2016 screening guidelines for Type 2 Diabetes; they cast a significantly wider net. They now recommend screening everyone over the age of 45. In addition, they are eliminating the term “diabetic” to describe a person living with diabetes. Dr. Linda Girgis, MD, family practitioner, talks about the impact the new guidelines will […]
Tackling CVD Residual Risk with Novel Therapies
Editor’s note: This article on CVD Residual Risk addresses the HCP treatment and management of patients living with diabetes who have an increased risk for heart disease. If you are interested in more information, check out our CME programs. An expert cardiologist, takes an in-depth look at CVD residual risk. Topics covered include reasons for […]
Melanoma: The Newest Immunotherapies and Target Drug Options
Melanoma accounts for less than two percent of all skin cancers but it is the cause of most skin cancer deaths. Just over 10,000 patients a year die from the disease. These sober statistics sparked a focus on new treatments to decrease mortality rates, such as BRAF and MEK inhibitors. The FDA has approved two […]
Acute Migraine Treatment Choices
Migraine headaches are a debilitating collection of neurological symptoms often accompanied by one or more of the following: visual disturbances, nausea, vomiting, dizziness, extreme sensitivity to sound, light, touch, and smell, and tingling or numbness in the extremities or face. A common disorder, about 30 million people in America suffer from this condition to varying […]
MRSA: Antimicrobial Advances of Gram-Positive Skin Infections
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium which causes infections in different parts of the body. In the United States, MRSA accounts for an average of 59 percent of all emergency room admissions for patients with skin and soft tissue infections (SSTI). Although this percentage varies across the country, clearly attention must be given to […]
Our First CME World Cancer Day Challenge
When did learning give back so much? From today through February 10th, join our World Cancer Day Challenge to earn CME and help us donate to cancer research at the same time! For every OMedLive session you attend, we’ll donate $10 to the American Cancer Society. For every CME credit hour claimed, we’ll boost […]
The War Against Invasive Mycoses: Keeping Patients Safe
When we take a look at the 10 most significant invasive fungal infections worldwide, over 2 million cases are reported each year, with a startlingly high average mortality rate of 45%. This war against invasive mycoses demands an urgent need for efficient diagnostic tests and safe and effective new drugs and vaccines. In this CME […]
Advanced NSCLC: Clinical Challenges for Personalized Treatment
According to the American Cancer Society, there were approximately 221,000 new cases of lung cancer in the U.S. in 2015. These patients accounted for about 13% of all new cancers. Of those, nearly 85-to-90 percent are non-small cell lung cancer (NSCLC). In this offering from OMedLive, Drs. Panos Fidias and Mark Socinski address some of […]
Gram-Negative Infections in the Hospital Setting
In this CME offering, Dr. Trevor Van Schooneveld uses clinical trial results, his personal knowledge, and his passion for Antimicrobial Stewardship as he explains how we can better treat in-hospital gram-negative infections. Dr. Schooneveld, Associate Professor of Infectious Disease as well as the Medical Director of the Antimicrobial Stewardship Program at the University of Nebraska […]
Biosimilars: The coming impact on American medicine
In March of 2015, the FDA approved the first biosimilar for use with American patients. In the next five years, the biosimilars market is expected to expand to $60 billion in sales in the U.S. and $127 billion worldwide. On February 1st, from 10 am – noon, EST, OMedLive in partnership with ClinicalSeriesLive, will be […]
Personalizing Treatment: A strategy to improve outcomes for patients with mCRC
Drs. Wasif Saif and Bert H. O’Neil take on some of the most recently approved treatment methods for metastatic colo-rectal cancer (mCRC) and compare their efficacy, risks, and benefits against other treatments options — some in use for the past half-century. Colo-rectal cancer is the second leading cause of cancer death in the United […]
Nursing Perspectives for Optimizing Hemophilia Treatment
In this OMedLive video, nurses Brenda Riske and Regina B. Butler discuss “optimizing outcomes in hemophilia treatment” from a nurse’s perspective. Hemophilia, a genetic bleeding disease, affects about 20,000 Americans and over 400,000 people worldwide. A rare and serious condition, it requires a vigilant medical team for optimal patient care. Brenda Riske, RN, MSN, MBA, […]
Optimal Treatments for Patients with Metastatic Pancreatic Cancer (MPCA)
In this continuing medical education video session, Dr. Tanios Bekaii-Saab tells us, “in the last 30 years, overall five-year relative survival rates increased for most cancers except for lung and pancreatic cancers, which have shown the least improvement.” Dr. Bekaii-Saab, MD, FACP from the Ohio State University James Cancer Hospital takes us through current modes […]
Migraine Symposium: Migraine Treatment Options
NeuroSeriesLive and Jefferson Headache Center announce their upcoming event about migraine treatments, which is entitled “Treatment Choices in Acute Migraine Management: Selecting Appropriate Use for Individual Patients.” The interactive online CME session includes Stephen D. Silberstein, MD and Michael J. Marmura, MD from the Center. Dr. Silberstein, the Director of the Jefferson Headache Center, Thomas […]
Creating Insulin Treatment Plans: Not a One-Size-Fits-All Approach
Individualized management of a patient’s insulin regimen is a must. It is not without many challenges, however, as Richard Beaser, MD, Associate Clinical Professor of Medicine at Harvard Medical School, George Dailey III, MD, Head of Diabetes Research and Medical Director of the Scripps Whittier Diabetes Institute, and Jason Gaglia, MD, MMSc, Assistant Professor of […]
Multiple Sclerosis (MS) Treatment Options
As a result of ongoing research, more treatment choices in MS care are available than ever before. In this video, “Treatment Choices in MS Care: Which is the Correct Disease-Modifying Therapy?,” Drs. Lisak and Cohen discuss the benefits and risks of several DMTs. Using results from clinical trials, MRI data, and discussion around case studies, […]
Updates on Bariatric Surgery
Drs. Caroline M. Apovian and Louis J. Aronne examine the 2013 AHA/ACC/TOS Guideline for Management of Overweight and Obesity in Adults, paying special attention to the recommendation to advise obese adults who meet criteria that surgery may be an option in “Updates in Bariatric Surgery: Guidelines, Patient Selection,” presented by DiabetesSeriesLive. Dr. Caroline M. Apovian, […]
Using Case Studies to Personalize Insulin Treatment Initiation and Therapies
Incorporating more insulin into a patient’s treatment plan can be difficult. In “Overcoming Barriers to Insulin Intensification: Case Discussions – Part 1,” diabetes experts address issues surrounding initial insulin treatment by examining case studies with the goal of helping clinicians learn how to approach common clinical scenarios. Presenters for this program include Richard Beaser, MD, […]
Telemedicine and Diabetes: The role physicians play with diabetic eye health
Primary care providers are often the first line of defense when it comes to diabetic eye health, according to physicians in the presentation “Diabetic Retinopathy: Role of the Primary Care Provider in the Optimal Care Model – Strategies for Prevention and Risk Reduction,” a CME video for the education summit DiabetesSeriesLive. Paolo S. Silva, MD, […]
Updates in Multiple Sclerosis Management: ECTRIMS 2015
The 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference, held October 7 through October 10, 2015, in Barcelona, Spain, featured presentations on personalized therapies, updated clinical trials, risk management, and therapeutic strategies for multiple sclerosis treatments. The treatments are likely to be ones doctors will explore for changing […]
An Ophthalmologist’s Role in Diabetic Retinopathy
Diabetic retinopathy treatment requires a team approach. A care team comprises primary care physicians, endocrinologists, ophthalmologists and other specialists. To gain insights into the emerging approaches from the ophthalmologist’s perspective, DiabetesSeries Live created “Achieving Better Outcomes for Patients With Diabetic Retinopathy: The Expanding Role of the Ophthalmologist.” This interactive presentation features speakers Andrew A. Moshfeghi, […]
Epilepsy Quality Measures
The 2014 update to the Centers for Medicare & Medicaid Services’ (CMS) Epilepsy Quality Measures focuses on seven guidelines that have a greater emphasis on recording and intervention than the previous 2009 measures, according to medical experts in “Adhering to the Epilepsy Quality Measurement Set Update,” a CME video presentation for the virtual education summit […]
Identifying and Treating Lennox-Gastaut Syndrome
Lennox-Gastaut Syndrome is a form of childhood epilepsy that requires careful diagnosis, treatment and transitional management into adulthood. In “Lennox-Gastaut Syndrome Across the Lifespan: Improving Diagnosis and Management,” a presentation from NeuroSeriesLive, experts Gregory L. Krauss, MD, from Johns Hopkins School of Medicine, and John M. Pellock, MD, at Virginia Commonwealth University discuss the condition […]
Alzheimer’s Diagnosis and Management
After more than three decades of using the same diagnostic criteria, recent research yielded a new set of standards for Alzheimer’s diagnosis. This new criteria impacts treatment strategies and offers hope for improving patient outcomes, according to medical experts in “Alzheimer’s Disease in 2015: Diagnosis and Management Across the Disease Spectrum,” a CME video presentation […]
Lennox-Gastaut Syndrome (LGS) Across the Lifespan
Lennox-GastautSyndrome (LGS) Virtual CME Symposium Live, Complimentary Online Medical Education Wednesday, November 4, 2015 from 11:00 am – 12:00 noon ET Featured Speakers Gregory L. Krauss, MD Johns Hopkins School of Medicine John M. Lellock, MD Virginia Commonwealth University Topics include Disease characteristics that may suggest a patient has LGS Differences associated with LGS […]
Understanding Dementia: A Physician Q&A
Our recent event, “New Direction in the Assessment and Management of Patients with Alzheimer’s Disease” was a success with several hundred doctors attending the interactive online broadcast. We compiled a Q&A section of questions from clinicians about the latest treatments, diagnostic options, and other related questions about dementia and Alzheimer’s. Dementia Treatment and Diagnostic Options […]